TY - JOUR AU - Quinn, M. A. AU - Benedet, J. L. AU - Odicino, F. AU - Maisonneuve, P. AU - Beller, U. AU - Creasman, W. T. PY - 2006 DA - 2006// TI - Carcinoma of the cervix uteri. FIGO 26th annual report on the results of treatment in gynecological Cancer JO - Int J Gynaecol Obstet VL - 95 UR - https://doi.org/10.1016/S0020-7292(06)60030-1 DO - 10.1016/S0020-7292(06)60030-1 ID - Quinn2006 ER - TY - JOUR AU - Morris, M. AU - Eifel, P. J. AU - Lu, J. AU - Grigsby, P. W. AU - Levenback, C. AU - Stevens, R. E. PY - 1999 DA - 1999// TI - Pelvic radiation with concurrent chemotherapy compared with pelvic and Para-aortic radiation for high-risk cervical cancer JO - N Engl J Med VL - 340 UR - https://doi.org/10.1056/NEJM199904153401501 DO - 10.1056/NEJM199904153401501 ID - Morris1999 ER - TY - STD TI - National Comprehensive Cancer Network. Cervical cancer clinical practice guidelines in oncology (v.I.2019). http://www.nccn.org/professionals/physician_gls/pdf/cervical.pdf. Accessed 27 Dec 2018. UR - http://www.nccn.org/professionals/physician_gls/pdf/cervical.pdf ID - ref3 ER - TY - JOUR AU - Cibula, D. AU - Pötter, R. AU - Planchamp, F. AU - Avall-Lundqvist, E. AU - Fischerova, D. AU - Haie Meder, C. PY - 2018 DA - 2018// TI - The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology guidelines for the management of patients with cervical cancer JO - Radiother Oncol VL - 127 UR - https://doi.org/10.1016/j.radonc.2018.03.003 DO - 10.1016/j.radonc.2018.03.003 ID - Cibula2018 ER - TY - JOUR AU - Moore, D. H. AU - Blessing, J. A. AU - McQuellon, R. P. AU - Thaler, H. T. AU - Cella, D. AU - Benda, J. PY - 2004 DA - 2004// TI - Phase III study of cisplatin with or without paclitaxel in stage IVB, recurrent, or persistent squamous cell carcinoma of the cervix: a gynecologic oncology group study JO - J Clin Oncol VL - 22 UR - https://doi.org/10.1200/JCO.2004.04.170 DO - 10.1200/JCO.2004.04.170 ID - Moore2004 ER - TY - JOUR AU - Monk, B. J. AU - Sill, M. W. AU - McMeekin, D. S. AU - Cohn, D. E. AU - Ramondetta, L. M. AU - Boardman, C. H. PY - 2009 DA - 2009// TI - Phase III trial of four cisplatin-containing doublet combinations in stage IVB, recurrent, or persistent cervical carcinoma: a gynecologic oncology group study JO - J Clin Oncol VL - 27 UR - https://doi.org/10.1200/JCO.2009.21.8909 DO - 10.1200/JCO.2009.21.8909 ID - Monk2009 ER - TY - JOUR AU - Kitagawa, R. AU - Katsumata, N. AU - Shibata, T. AU - Kamura, T. AU - Kasamatsu, T. AU - Nakanishi, T. PY - 2015 DA - 2015// TI - Paclitaxel plus carboplatin versus paclitaxel plus cisplatin in metastatic or recurrent cervical cancer: the open-label randomized phase III trial JCOG0505 JO - J Clin Oncol VL - 33 UR - https://doi.org/10.1200/JCO.2014.58.4391 DO - 10.1200/JCO.2014.58.4391 ID - Kitagawa2015 ER - TY - JOUR AU - Ning, M. S. AU - Ahobila, V. AU - Jhingran, A. AU - Stecklein, S. R. AU - Frumovitz, M. AU - Schmeler, K. M. PY - 2018 DA - 2018// TI - Outcomes and patterns of relapse after definitive radiation therapy for oligometastatic cervical cancer JO - Gynecol Oncol VL - 148 UR - https://doi.org/10.1016/j.ygyno.2017.10.017 DO - 10.1016/j.ygyno.2017.10.017 ID - Ning2018 ER - TY - JOUR AU - Rusthoven, C. G. AU - Jones, B. L. AU - Flaig, T. W. AU - Crawford, E. D. AU - Koshy, M. AU - Sher, D. J. PY - 2016 DA - 2016// TI - Improved survival with prostate radiation in addition to androgen deprivation therapy for men with newly diagnosed metastatic prostate cancer JO - J Clin Oncol VL - 34 UR - https://doi.org/10.1200/JCO.2016.67.4788 DO - 10.1200/JCO.2016.67.4788 ID - Rusthoven2016 ER - TY - JOUR AU - Gomez, D. R. AU - Blumenschein, G. R. AU - Lee, J. J. AU - Hernandez, M. AU - Ye, R. AU - Camidge, D. R. PY - 2016 DA - 2016// TI - Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study JO - Lancet Oncol VL - 17 UR - https://doi.org/10.1016/S1470-2045(16)30532-0 DO - 10.1016/S1470-2045(16)30532-0 ID - Gomez2016 ER - TY - JOUR AU - Kim, K. AU - Cho, S. Y. AU - Kim, B. J. AU - Kim, M. H. AU - Choi, S. C. AU - Ryu, S. Y. PY - 2010 DA - 2010// TI - The type of metastasis is a prognostic factor in disseminated cervical cancer JO - J Gynecol Oncol VL - 21 UR - https://doi.org/10.3802/jgo.2010.21.3.186 DO - 10.3802/jgo.2010.21.3.186 ID - Kim2010 ER - TY - JOUR AU - Li, H. AU - Wu, X. AU - Cheng, X. PY - 2016 DA - 2016// TI - Advances in diagnosis and treatment of metastatic cervical cancer JO - J Gynecol Oncol VL - 27 UR - https://doi.org/10.3802/jgo.2016.27.e43 DO - 10.3802/jgo.2016.27.e43 ID - Li2016 ER - TY - JOUR AU - Usami, T. AU - Takahashi, A. AU - Matoda, M. AU - Okamoto, S. AU - Kondo, E. AU - Kanao, H. PY - 2016 DA - 2016// TI - Review of treatment and prognosis of stage IVB cervical carcinoma JO - Int J Gynecol Cancer VL - 26 UR - https://doi.org/10.1097/IGC.0000000000000771 DO - 10.1097/IGC.0000000000000771 ID - Usami2016 ER - TY - JOUR AU - Tangjitgamol, S. AU - Levenback, C. F. AU - Beller, U. AU - Kavanagh, J. J. PY - 2004 DA - 2004// TI - Role of surgical resection for lung, liver, and central nervous system metastases in patients with gynecological cancer: a literature review JO - Int J Gynecol Cancer VL - 14 UR - https://doi.org/10.1111/j.1048-891x.2004.14326.x DO - 10.1111/j.1048-891x.2004.14326.x ID - Tangjitgamol2004 ER - TY - JOUR AU - Wang, Y. AU - Farmer, M. AU - Izaguirre, E. W. AU - Schwartz, D. L. AU - Somer, B. AU - Tillmanns, T. PY - 2018 DA - 2018// TI - Association of Definitive Pelvic Radiation Therapy with Survival among Patients with Newly Diagnosed Metastatic Cervical Cancer JO - JAMA Oncol VL - 4 UR - https://doi.org/10.1001/jamaoncol.2018.2677 DO - 10.1001/jamaoncol.2018.2677 ID - Wang2018 ER - TY - JOUR AU - Zighelboim, I. AU - Taylor, N. P. AU - Powell, M. A. AU - Gibb, R. K. AU - Rader, J. S. AU - Mutch, D. G. PY - 2006 DA - 2006// TI - Outcomes in 24 selected patients with stage IVB cervical cancer and excellent performancestatus treated with radiotherapy and chemotherapy JO - Radiat Med VL - 24 UR - https://doi.org/10.1007/s11604-006-0082-6 DO - 10.1007/s11604-006-0082-6 ID - Zighelboim2006 ER - TY - JOUR AU - Im, J. H. AU - Yoon, H. I. AU - Kim, S. AU - Nam, E. J. AU - Kim, S. W. AU - Yim, G. W. PY - 2015 DA - 2015// TI - Tailored radiotherapeutic strategies for disseminated uterine cervical cancer patients JO - Radiat Oncol VL - 10 UR - https://doi.org/10.1186/s13014-015-0373-0 DO - 10.1186/s13014-015-0373-0 ID - Im2015 ER - TY - JOUR AU - Tewari, K. S. AU - Sill, M. W. AU - Penson, R. T. AU - Huang, H. AU - Ramondetta, L. M. AU - Landrum, L. M. PY - 2017 DA - 2017// TI - Bevacizumab for advanced cervical cancer: final overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial (gynecologic oncology group 240) JO - Lancet. VL - 390 UR - https://doi.org/10.1016/S0140-6736(17)31607-0 DO - 10.1016/S0140-6736(17)31607-0 ID - Tewari2017 ER - TY - JOUR AU - Heong, V. AU - Ngoi, N. AU - Tan, D. S. PY - 2017 DA - 2017// TI - Update on immune checkpoint inhibitors in gynecological cancers JO - J Gynecol Oncol VL - 28 UR - https://doi.org/10.3802/jgo.2017.28.e20 DO - 10.3802/jgo.2017.28.e20 ID - Heong2017 ER -